Literature DB >> 15302609

Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer.

Hikmet Koçak1, Yildiz Oner-Iyidoğan, Taner Koçak, Pernur Oner.   

Abstract

OBJECTIVES: This study was planned to evaluate the feasibility of the assay of leukocyte arylsulfatase-A (AS-A) activity, and some urinary cytokine levels (tumor necrosis factor-alpha [TNF-alpha] and interleukin-8 [IL-8]), as noninvasive diagnostic tools in different stages of bladder cancer patients. DESIGN AND METHODS: Blood and urine samples of 79 subjects were analyzed, including 28 healthy volunteers, 27 patients with superficial bladder cancer (SBC), and 24 patients with muscle invasive bladder cancer (MIBC).
RESULTS: In SBC patients, the mean leukocyte AS-A activity was slightly higher (11.4%) than healthy subjects without reaching statistical significance. On the other hand, the enzyme activity in MIBC patients was significantly higher than those of controls (38.9%) and SBC patients (18.3%). Urinary TNF-alpha levels in both cancer groups were not significantly different from the control group. Urinary IL-8 levels of MIBC patients were significantly increased when compared with the levels of SBC patients and healthy subjects (P < 0.001).
CONCLUSIONS: Based on our results, it may be concluded that measurement of leukocyte AS-A activity is not a sufficiently reliable noninvasive diagnostic test in distinguishing early stage bladder cancer from healthy subjects as well as detecting disease progression. Whereas measurement of urinary IL-8 may be valuable as a noninvasive diagnostic and prognostic test especially in patients with advanced bladder cancer. It also appears that complementary biochemical information may be obtained about the prognosis of the disease by monitoring urinary IL-8 profile. However, further confirmatory clinical trials about the prognostic value of the measurement of urinary IL-8 are needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302609     DOI: 10.1016/j.clinbiochem.2004.02.005

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

1.  High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin therapy: A long-term survival analysis.

Authors:  Kai Qu; Jian Gu; Yuanqing Ye; Stephen B Williams; Colin P Dinney; Xifeng Wu; Ashish Kamat
Journal:  Oncoimmunology       Date:  2017-01-03       Impact factor: 8.110

2.  Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.

Authors:  Adam R Metwalli; Sanaz Khanbolooki; Goodwin Jinesh; Debasish Sundi; Jay B Shah; Marissa Shrader; Woonyoung Choi; Laura M Lashinger; Srinivas Chunduru; David J McConkey; Mark McKinlay; Ashish M Kamat
Journal:  Cancer Biol Ther       Date:  2010-11-01       Impact factor: 4.742

3.  Interleukin 8 (IL-8) - a universal biomarker?

Authors:  Aamir Shahzad; Martin Knapp; Irene Lang; Gottfried Köhler
Journal:  Int Arch Med       Date:  2010-06-15

4.  Expression of pigment epithelium-derived factor in bladder tumour is correlated with interleukin-8 yet not with interleukin-1α.

Authors:  Chenchen Feng; Ming Guan; Qiang Ding; Yuanfang Zhang; Haowen Jiang; Hui Wen; Paohsun Wang; Zhong Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

5.  A four-gene signature predicts disease progression in muscle invasive bladder cancer.

Authors:  Wun-Jae Kim; Seon-Kyu Kim; Pildu Jeong; Seok-Joong Yun; In-Chang Cho; Isaac Yi Kim; Sung-Kwon Moon; Hong-Duck Um; Yung Hyun Choi
Journal:  Mol Med       Date:  2011-02-04       Impact factor: 6.354

6.  Serum sulfatase activity is more elevated in colonic adenomas than cancers.

Authors:  Malgorzata Matusiewicz; Malgorzata Krzystek-Korpacka; Dorota Diakowska; Krzysztof Grabowski; Katarzyna Augoff; Katarzyna Blachut; Leszek Paradowski; Irena Kustrzeba-Wojcicka; Michal Piast; Teresa Banas
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

7.  IL-8 as a urinary biomarker for the detection of bladder cancer.

Authors:  Virginia Urquidi; Myron Chang; Yunfeng Dai; Jeongsoon Kim; Edward D Wolfson; Steve Goodison; Charles J Rosser
Journal:  BMC Urol       Date:  2012-05-04       Impact factor: 2.264

8.  The use of fluorescence correlation spectroscopy (FCS) as an alternative biomarker detection technique: a preliminary study.

Authors:  Aamir Shahzad; Martin Knapp; Irene Lang; Gottfried Köhler
Journal:  J Cell Mol Med       Date:  2011-12       Impact factor: 5.310

9.  A multi-analyte assay for the non-invasive detection of bladder cancer.

Authors:  Steve Goodison; Myron Chang; Yunfeng Dai; Virginia Urquidi; Charles J Rosser
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

10.  Genotyping of IL-8-251 T > A yields prognostic information in patients with gastric carcinoma.

Authors:  Xiuyu Cai; Weihan Hu; Bei Zhang; Ni Dai; Ruihua Xu; Huijuan Qiu; Deshen Wang; Zhiming Li; Wenqi Jiang
Journal:  Biomarkers       Date:  2013-08-28       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.